GlaxoSmithKline (India)

Recent papers from GlaxoSmithKline (India)

1. Integrating Efficacy and Effectiveness Evidence from Randomized Controlled Trials and Real-World Studies of Inhaled Corticosteroid/Long-Acting β2-Agonist Therapies in Moderate AsthmaPulmonary Therapy · 2026
2. Gepotidacin and Early Symptom Improvement in Uncomplicated Urinary Tract InfectionJAMA Network Open · 2026
3. Posttraumatic Stress Disorder, Health-Related Social Needs, and Cognitive Outcomes in US VeteransJAMA Network Open · 2026
4. Unravelling the Itch: Cross‐Sectional Analysis of Pruritus Patterns in the PicnicHealth Primary Biliary Cholangitis RegistryLiver International · 2026
5. Phase 2 Evaluation of two GEO-CM04S1 Dose Levels Shows Comparable Safety and Broad ImmunogenicityJournal of Infection · 2026
6. Temporal effects of Palmitoylethanolamide (PEA) in modulating knee osteoarthritis symptoms: A randomized, double-blind, placebo-controlled trialJournal of Back and Musculoskeletal Rehabilitation · 2026
7. Simultaneous determination and ADME profiling of betulinic and ursolic acids from Avicennia marina in Wistar ratsDiscover Pharmaceutical Sciences · 2026
8. Optimising Pharmacovigilance Efficiency with MLIT (Machine Learning for Intelligent Triage): A Tool for Statistical Safety AlertsDrug Safety · 2026
9. Site-specific and global glycan analysis of the human cytomegalovirus pentameric glycoprotein by high resolution mass spectrometryGlycobiology · 2026
10. Long-Acting Cabotegravir Injections Are More Acceptable Than Long-Acting Lenacapavir Injections After One Dose: Results From the CLARITY Randomized Crossover StudyAdvances in Therapy · 2026
11. Clinical Remission with FF/UMEC/VI Versus ICS/LABA in Uncontrolled Asthma: The PERFORM Pragmatic Randomized Controlled TrialAdvances in Therapy · 2026
12. Type 3 fimbrial regulation underpins anti-MrkA immunotherapeutic efficacy in experimental Klebsiella pneumoniae infectionThe Journal of Infectious Diseases · 2026
13. Validation of a Herpes Zoster Conceptual Model on Quality of Life in East AsiaValue in Health Regional Issues · 2026
14. Developing low-carbon salbutamol MDI: assessment of relative bioavailability and pharmacodynamic relative potency of salbutamol MDI with propellant HFA-152aBMJ Open Respiratory Research · 2026
15. Interleukin 23 promotes a pro-inflammatory Th17 cell state by stabilizing RORγt and suppressing glucocorticoid receptor activityImmunity · 2026
16. Estimated efficacy of the adjuvanted RSVPreF3 vaccine against diverse and worldwide predominant RSV strains, irrespective of RSV F protein variation: results of a post-hoc analysis from the AReSVi-006 trialEBioMedicine · 2026
17. A34-11 Mepolizumab Reduces the Burden of Chronic Obstructive Pulmonary Disease Exacerbations in a Wide Spectrum of Patients: Pooled Results From Phase III Randomized Controlled TrialsAmerican Journal of Respiratory and Critical Care Medicine · 2026
18. A34-21 Disease Stability Is Achievable in a Wide Spectrum of Patients With Chronic Obstructive Pulmonary Disease Receiving Mepolizumab: Pooled Results From Phase III Randomized Controlled TrialsAmerican Journal of Respiratory and Critical Care Medicine · 2026
19. Real-world monitoring and clinical management of decreased platelet counts in patients with epithelial ovarian cancer who received first-line maintenance niraparib in the ACTIV1ZE studyGynecologic Oncology · 2026
20. Rega: A Platform for the Prediction of the Regioselectivity of C–H Functionalization ReactionsJournal of Chemical Information and Modeling · 2026